On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...

RTN-001 is under clinical development by Retension Pharmaceuticals and currently in Phase II for Hypertension.

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

The study highlighted interventions to reduce heart failure risk — most notably hypertension control and weight loss.

Adequate Sleep Significantly Reduces the Risk of Hypertension in Adolescents Nov. 11, 2024 — Adolescents who meet the recommended guidelines of nine to 11 hours of sleep per day were shown to ...

Short sleep duration that persists during pregnancy and for two to seven years after delivery is associated with incre ...

The prevalence of idiopathic intracranial hypertension in US women varies geographically, some of which is explained by the varying prevalence of obesity.

Physician researchers found 39 weeks of gestation is optimal for delivery in mothers with chronic hypertension.

Hypertension can lead to serious health issues without presenting noticeable symptoms. Despite this, it remains one of the ...

Dietary Changes: Reduce sodium intake by avoiding processed foods. Instead, opt for potassium-rich options like bananas, ...